Kentaro Takeda

32PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 25, 2026
A seamless dose-optimization design for monotherapy and combination therapy.

|Oct 05, 2026
BOIN12-PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression-Free Survival Endpoint.

|Aug 14, 2026
A Randomized Basket Trial Design for Dose Optimization Based on Bayesian Model Averaging Using Spike-and-Slab Priors.

|Jul 07, 2026
A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials.

|Apr 19, 2026
A Seamless Two-Stage Phase I/II Trial Design With Backfill and Joint Monitoring for Dose Optimization.

|Mar 29, 2026
A Constrained Hierarchical Bayesian Model Considering Latent Biomarker Subgroups for Time-To-Event Endpoints in Randomized Phase II Trials.

Yifei Huang, Kentaro Takeda, Yongyun Zhao

Pageof 6

Frequent Collaborators

4 joint publications

Yusuke Yamaguchi

3 joint publications

Akihiro Hirakawa

2 joint publications

Masahiro Kojima

2 joint publications

Hiroyuki Sato